Ontology highlight
ABSTRACT:
SUBMITTER: Hao Q
PROVIDER: S-EPMC6516871 | biostudies-literature | 2018 Dec
REPOSITORIES: biostudies-literature
Hao Qiukui Q Dong Bi Rong BR Yue Jirong J Wu Taixiang T Liu Guan J GJ
The Cochrane database of systematic reviews 20181218
<h4>Background</h4>Thrombolytic therapy is usually reserved for patients with clinically serious or massive pulmonary embolism (PE). Evidence suggests that thrombolytic agents may dissolve blood clots more rapidly than heparin and may reduce the death rate associated with PE. However, there are still concerns about the possible risk of adverse effects of thrombolytic therapy, such as major or minor haemorrhage. This is the third update of the Cochrane review first published in 2006.<h4>Objective ...[more]